Pasadena Private Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$315K Buy
2,615
+20
+0.8% +$2.31K 0.04% 168
2025
Q4
$273K Buy
2,595
+110
+4% +$10.3K 0.04% 186
2025
Q3
$209K Sell
2,485
-100
-4% -$8.24K 0.03% 189
2025
Q2
$205K Sell
2,585
-750
-22% -$59.6K 0.04% 179
2025
Q1
$299K Sell
3,335
-175
-5% -$16.3K 0.06% 144
2024
Q4
$349K Buy
3,510
+200
+6% +$20.6K 0.07% 113
2024
Q3
$376K Hold
3,310
0.08% 103
2024
Q2
$410K Hold
3,310
0.09% 91
2024
Q1
$437K Hold
3,310
0.1% 87
2023
Q4
$361K Buy
3,310
+25
+0.8% +$2.6K 0.09% 95
2023
Q3
$338K Hold
3,285
0.1% 65
2023
Q2
$379K Sell
3,285
-1
-0% -$114 0.11% 65
2023
Q1
$350K Buy
3,286
+1
+0% +$108 0.1% 69
2022
Q4
$365K Sell
3,285
-262
-7% -$26.8K 0.11% 62
2022
Q3
$305K Buy
3,547
+251
+8% +$22.4K 0.11% 60
2022
Q2
$301K Buy
3,296
+1
+0% +$89 0.1% 59
2022
Q1
$270K Sell
3,295
-449
-12% -$35.4K 0.09% 69
2021
Q4
$287K Buy
3,744
+670
+22% +$53.4K 0.09% 76
2021
Q3
$231K Hold
3,074
0.08% 71
2021
Q2
$239K Sell
3,074
-148
-5% -$11K 0.08% 71
2021
Q1
$237K Hold
3,222
0.09% 68
2020
Q4
$251K Hold
3,222
0.09% 62
2020
Q3
$255K Hold
3,222
0.1% 54
2020
Q2
$238K Hold
3,222
0.09% 59
2020
Q1
$251K Buy
3,222
+472
+17% +$37.1K 0.1% 60
2019
Q4
$239K Hold
2,750
0.1% 55
2019
Q3
$221K Hold
2,750
0.1% 53
2019
Q2
$220K Sell
2,750
-169
-6% -$12.9K 0.1% 49
2019
Q1
$232K Buy
+2,919
New +$218K 0.25% 38

Other funds holding MRK

Pasadena Private Wealth's MRK Position: Q1 2026 in Review

Pasadena Private Wealth increased its Merck (MRK) stake by 0.77% in Q1 2026, buying an estimated $2.31K and bringing the position to 2,615 shares worth $315K. The position accounts for 0.04% of the portfolio, ranked #168.

Pasadena Private Wealth first reported a position in MRK in Q1 2019 and has held it in 29 quarters since. The position peaked at $437K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Pasadena Private Wealth held 2,615 shares of Merck worth $315K as of Q1 2026.
  • Pasadena Private Wealth bought 20 Merck shares in Q1 2026, an estimated $2.31K.
  • Merck made up 0.04% of Pasadena Private Wealth's portfolio in Q1 2026, its #168 holding.
  • Pasadena Private Wealth first reported a position in Merck in Q1 2019 and has held it in 29 quarters since.
  • Pasadena Private Wealth's Merck position peaked at $437K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Pasadena Private Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.